C4 Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in C4 Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including C4 Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in C4 Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $120k | 33k | 3.60 |
| 2024-09-30 | $147k | 26k | 5.70 |
| 2024-06-30 | $116k | 25k | 4.62 |
| 2024-03-31 | $49 | 6 | 8.17 |
| 2023-12-31 | $39k | 6.9k | 5.65 |
| 2023-09-30 | $17k | 9.1k | 1.86 |
| 2023-06-30 | $4.1k | 1.5k | 2.75 |
| 2023-03-31 | $9.0k | 1.6k | 5.46 |
| 2022-12-31 | $600k | 101k | 5.97 |
| 2022-06-30 | $185k | 25k | 7.48 |
| 2022-03-31 | $1.7M | 69k | 24.26 |
| 2021-12-31 | $924k | 29k | 32.18 |
| 2021-03-31 | $231k | 6.2k | 37.12 |
| 2020-12-31 | $159k | 4.8k | 33.23 |